4,810
Views
24
CrossRef citations to date
0
Altmetric
Research Papers

Integrative group-based cognitive rehabilitation efficacy in multiple sclerosis: a randomized clinical trial

, , , , , , , & show all
Pages 208-216 | Received 04 Mar 2016, Accepted 15 Oct 2016, Published online: 07 Dec 2016

References

  • Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7:1139–1151.
  • Kalmar JH, Gaudino EA, Moore NB, et al. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis. Neuropsychology. 2008;22:442–449.
  • Ben Ari E, Johansson S, Ytterberg C, et al. How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis? Disabil Rehabil. 2014;36:2012–2018.
  • Strober L, Chiaravalloti N, Moore N, et al. Unemployment in multiple sclerosis (MS): utility of the MS functional composite and cognitive testing. Mult Scler. 2014;20:112–115.
  • Hakim E, Bakheit A, Bryant T, et al. The social impact of multiple sclerosis – a study of 305 patients and their relatives. Disabil Rehabil. 2000;22:288–293.
  • Ford HL, Gerry E, Johnson MH, et al. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil. 2001;23:516–521.
  • Benito-León J, Manuel Morales J, Rivera-Navarro J, et al. A review about the impact of multiple sclerosis on health-related quality of life. Disabil Rehabil. 2003;25:1291–1303.
  • Fernández O, Baumstarck-Barrau K, Simeoni MC, MusiQoL study group, et al. Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: assessment using the MusiQoL and SF-36 questionnaires. Mult Scler. 2011;17:1238–1249.
  • Ruet A, Deloire M, Hamel D, et al. Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study. J Neurol. 2013;260:776–784.
  • Amato MP, Langdon D, Montalban X, et al. Treatment of cognitive impairment in multiple sclerosis: position paper. J Neurol. 2013;260:1452–1468.
  • Thomas PW, Thomas S, Hillier C, et al. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev. 2006;1:CD004431.
  • O’Brien AR, Chiaravalloti N, Goverover Y, et al. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature. Arch Phys Med Rehabil. 2008;89:761–769.
  • Rosti-Otajärvi EM, Hämäläinen PI. Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev. 2014;2:CD009131.
  • Chiaravalloti ND, Moore NB, Nikelshpur OM, et al. An RCT to treat learning impairment in multiple sclerosis: the MEMREHAB trial. Neurology. 2013;81:2066–2072.
  • Leavitt VM, Wylie GR, Girgis PA, et al. Increased functional connectivity within memory networks following memory rehabilitation in multiple sclerosis. Brain Imaging Behav. 2014;8:394–402.
  • Mattioli F, Stampatori C, Bellomi F, et al. Neuropsychological rehabilitation in adult multiple sclerosis. J Neurol Sci. 2010;31:271–274.
  • Filippi M, Riccitelli G, Mattioli F, et al. Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures – an explorative study. Radiology. 2012;262:932–940.
  • Parisi L, Rocca MA, Mattioli F, et al. Changes of brain resting state functional connectivity predict the persistence of cognitive rehabilitation effects in patients with multiple sclerosis. Mult Scler. 2013;20:686–694.
  • Stuifbergen AK, Becker H, Perez F, et al. A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis. Clin Rehabil. 2012;26:882–893.
  • Brissart H, Leroy M, Morele E, et al. Cognitive rehabilitation in multiple sclerosis. Neurocase. 2013;19:553–565.
  • Carr SE, das Nair R, Schwartz AF, et al. Group memory rehabilitation for people with multiple sclerosis: a feasibility randomized controlled trial. Clin Rehabil. 2014;28:552–561.
  • Graziano F, Calandri E, Borghi M, et al. The effects of a group-based cognitive behavioral therapy on people with multiple sclerosis: a randomized controlled trial. Clin Rehabil. 2014;28:264–274.
  • Ojeda N, Peña J. REHACOP: programa de rehabilitación neuropsicológica en psicosis. 1st ed. Bilbao: Parima Digital, S.L.; 2012.
  • Sánchez P, Peña J, Bengoetxea E, et al. Improvements in negative symptoms and functional outcome after a new generation cognitive remediation program: a randomized controlled trial. Schizophr Bull. 2014;40:707–715.
  • Pena J, Ibarretxe-Bilbao N, Garcia-Gorostiaga I, et al. Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology. 2014;83:2167–2174.
  • Tamminga C, Holcomb H. Phenotype of schizophrenia: a review and formulation. Mol Psychiatry. 2005;10:27–39.
  • Alves G, Forsaa EB, Pedersen KF, et al. Epidemiology of Parkinson’s disease. J Neurol. 2008;255:18–32.
  • Kamm CP, Uitdehaag BM, Polman CH. Multiple sclerosis: current knowledge and future outlook. Eur Neurol. 2014;72:132–141.
  • Bowie CR, Harvey PD. Cognitive deficits and functional outcome in schizophrenia. Neuropsychiatr Dis Treat. 2006;2:531–536.
  • Palavra NC, Naismith SL, Lewis SJ. Mild cognitive impairment in Parkinson’s disease: a review of current concepts. Neurol Res Int. 2013;2013:1–8.
  • McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121–127.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
  • Cerasa A, Gioia MC, Valentino P, et al. Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates. Neurorehabil Neural Repair. 2013;27:284–295.
  • Faul F, Erdfelder E, Lang A, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–191.
  • Schretlen DJ. Brief test of attention professional manual. Odesa (FL): Psychological Assessment Resources; 1997.
  • Smith A. Test de símbolos y dígitos. Madrid: TEA Ediciones; 2002.
  • Reitan R, Wolfson D. The Halstead-Reitan neuropsychological test battery. Tucson: Neuropsychology Press; 1985.
  • Salthouse TA, Babcock RL. Decomposing adult age differences in working memory. Dev Psychol. 1991;27:763–776.
  • Weschler D. Escala de inteligencia de Weschler para adultos-III. Madrid: TEA Ediciones; 2002.
  • Brandt J, Benedict RH. Hopkins verbal learning test-revised: professional manual. Lutz (FL): Psychological Assessment Resources; 2001.
  • Schretlen DJ, Vannorsdall TD. Calibrated ideational fluency assessment (CIFA) professional manual. Lutz (FL): Psychological Assessment Resources; 2010.
  • Golden CJ. STROOP: test de colores y palabras. Madrid: TEA Ediciones; 2001.
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1452.
  • Gomar JJ, Ortiz-Gil J, McKenna PJ, et al. Validation of the word accentuation test (TAP) as a means of estimating premorbid IQ in Spanish speakers. Schizophr Res. 2011;128:175–176.
  • Rami L, Valls-Pedret C, Bartrés-Faz D, et al. Cuestionario de reserva cognitiva. Valores obtenidos en población anciana sana y con enfermedad de Alzheimer. Rev Neurol. 2011;52:195–201.
  • Martínez J, Onís M, Dueñas R, et al. Versión española del cuestionario de Yesavage abreviado (GDS) para el despistaje de depresión en mayores de 65 años: adaptación y validación. Medifam. 2002;12:620–630.
  • Krupp LB, LaRocca NG, Muir-Nash J, et al. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46:1121–1123.
  • Deloire MS, Bonnet MC, Salort E, et al. How to detect cognitive dysfunction at early stages of multiple sclerosis? Mult Scler. 2006;12:445–452.
  • Van Breukelen GJ. ANCOVA versus change from baseline had more power in randomized studies and more bias in nonrandomized studies. J Clin Epidemiol. 2006;59:920–925.
  • Fink F, Rischkau E, Butt M, et al. Efficacy of an executive function intervention programme in MS: a placebo-controlled and pseudo-randomized trial. Mult Scler. 2010;16:1148–1151.
  • Vogt A, Kappos L, Calabrese P, et al. Working memory training in patients with multiple sclerosis – comparison of two different training schedules. Restor Neurol Neurosci. 2009;27:225–235.
  • Hildebrandt H, Lanz M, Hahn H, et al. Cognitive training in MS: effects and relation to brain atrophy. Restor Neurol Neurosci. 2007;25:33–43.
  • Chiaravalloti ND, DeLuca J, Moore NB, et al. Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial. Mult Scler. 2005;11:58–68.
  • Chiaravalloti ND, DeLuca J. Self-generation as a means of maximizing learning in multiple sclerosis: an application of the generation effect. Arch Phys Med Rehabil. 2002;83:1070–1079.
  • das Nair R, Martin KJ, Lincoln NB. Memory rehabilitation for people withmultiple sclerosis. Cochrane Database Syst Rev. 2016;3:CD008754.
  • Amato MP, Goretti B, Viterbo RG, et al. Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial. Mult Scler. 2014;20:91–98.
  • Chiaravalloti ND, Wylie G, Leavitt V, et al. Increased cerebral activation after behavioral treatment for memory deficits in MS. J Neurol. 2012;259:1337–1346.